HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. (HIMS) shares fell nearly 12.9% in pre-market trading following its Q2 2025 earnings report, which saw both EPS of 17 cents and revenues of $544.8 million miss Zacks Consensus Estimates, despite robust 72.6% year-over-year revenue growth. The primary concern was a significant 491 basis point contraction in gross margin to 76.4%, driven by surging marketing and technology expenditures, overshadowing a 74.9% increase in online revenues and strong subscriber growth. While the company maintained a positive revenue outlook for Q3 and full-year 2025, the pressure on profitability from rising costs impacted investor sentiment.

Analysis

Hims & Hers Health, Inc. (HIMS) reported a dichotomous second quarter, characterized by robust top-line expansion that failed to meet market expectations, resulting in a 12.9% pre-market share price decline. While revenue surged 72.6% year-over-year to $544.8 million, it missed consensus estimates by 1.5%, and the EPS of 17 cents fell short by a penny. The core growth engine remains the Online channel, which saw revenues climb 74.9%, driven by a 30.8% increase in subscribers to 2.4 million and a 29.8% rise in monthly online revenue per subscriber to $74, indicating successful upselling of personalized offerings such as GLP-1 products. However, the primary concern for investors is a significant 491 basis point contraction in gross margin to 76.4%, attributed to rising product costs. This was partially offset at the operational level, where operating margin expanded by 141 bps to 4.9% as revenue growth outpaced the 58.6% increase in operating expenses. Management's confidence is reflected in its reiterated full-year 2025 revenue guidance and strategic moves like the ZAVA acquisition for European expansion, yet the market's immediate focus is on the erosion of gross profitability despite impressive user and revenue growth.

Key Decisions for Investors

• Investors should scrutinize the gross margin pressure, as the 491 bps contraction signals that rising product and marketing costs are challenging profitability, which could cap upside despite strong top-line growth.
• The 12.9% stock pullback could present an opportunity for growth-focused investors, given that the underlying business metrics, including a 30.8% subscriber increase and a 29.8% rise in revenue per user, remain exceptionally strong.
• Monitor the company's ability to maintain operating leverage, as the expansion in operating margin suggests management can control costs relative to its rapid scaling, a key factor for long-term value creation.
• Factor in the strategic potential of the recent ZAVA acquisition and planned 2026 Canadian entry, as successful international expansion could serve as a major future growth catalyst, justifying a premium valuation.